Clinical evaluation of hydration index using a corneometer in metastatic melanoma patients treated with BRAF/MEK inhibitors: a prospective study

被引：0
|
作者：
Amabile, Simone [1 ]
Tonella, Luca [1 ]
Rubatto, Marco [1 ]
Argenziano, Giuseppe [2 ]
Babino, Graziella [2 ]
Frascione, Pasquale [3 ]
Dika, Emi [4 ,5 ]
Giacomelli, Luca [6 ]
Parodi, Aurora [7 ]
Quaglino, Pietro [1 ]
机构：
[1] Univ Turin, Dermatol Clin, Sch Med, Turin, Italy
[2] Univ Campania, Dermatol Unit, Naples, Italy
[3] Dermatol Hosp San Gallicano, Oncol Dermatol & Skin Tumor Prevent Unit, Rome, Italy
[4] IRCCS Azienda Osped Univ Bologna, Dermatol, Bologna, Italy
[5] Univ Bologna, Dermatol, Dept Expt Diagnost & Specialty Med DIMES, Bologna, Italy
[6] Polistudium SRL, Milan, Italy
[7] Univ Genoa, Dermatol Clin, Genoa, Italy
来源：
EUROPEAN JOURNAL OF DERMATOLOGY | 2022年 / 32卷 / 01期
关键词：
D O I：
10.1684/ejd.2022.4198
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：126 / 127
页数：2
相关论文
共 50 条
  • [31] Retreatment and rechallenge with BRAF/MEK inhibitors in patients with metastatic melanoma: Results from the observational study GEM1801
    de Miguel, Pablo Ayala
    Berciano-Guerrero, Miguel-Angel
    Munoz-Couselo, Eva
    Manzano, Jose Luis
    Fuentes, Pablo Cerezuela
    Rivas, Ainara Soria
    Castano, Almudena Garcia
    Crespo, Guillermo
    Puertolas, Teresa
    De La Rosa, Carlos Aguado
    Sanz, Lourdes Gutierrez
    Castro, Rafael Lopez
    Espinosa, Enrique
    Lecumberri, Maria Jose
    Majem, Margarita
    Martinez, Javier Medina
    Bellido, Lorena
    Fernandez, Luis Antonio
    Martin-Algarra, Salvador
    Marquez-Rodas, Ivan
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [32] Predictive value of integrative epigenetic profiling in metastatic melanoma (MM) patients (p) treated with BRAF/MEK inhibitors (BMI) and chemotherapy (CT).
    Luis Manzano, Jose
    Martinez Cardus, Anna
    Teresa Fernandez-Figueras, Maria
    Boada, Aram
    Luis Cuadra-Urteaga, Jose
    Morain, Sebastian
    Buges, Cristina
    de los Llanos Gil, Maria
    Layos, Laura
    Indacochea, Alberto
    Vila Martinez, Laia
    Hardy, Max
    Teruel, Iris
    Martinez-Balibrea, Eva
    Esteller, Manel
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [33] Comparative risks of cardiotoxicity following initiation of checkpoint inhibitors, BRAF/MEK inhibitors, and interferon alpha in patients with metastatic melanoma
    Bates, Benjamin
    Gandhi, Poonam
    Setoguchi, Soko
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 40 - 40
  • [34] Metastatic melanoma response to combination therapy with BRAF and MEK inhibitors: a FDG PET/CT pilot study
    Burroni, L.
    Fringuelli, F.
    Biscontini, G.
    Palucci, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S586 - S587
  • [35] Urgent treatment of patients with metastatic melanoma using braf inhibitors in the absence of braf mutation status
    Nathan, P.
    Sharma, A.
    Lorigan, P.
    ANNALS OF ONCOLOGY, 2013, 24 (06) : 1712 - 1713
  • [36] Severe Colitis in 2 Patients with Melanoma Treated with BRAF/MEK Inhibitors: Case Report and Literature Review
    Wautier, Chloe
    Gourmaud, Jolanta
    Dong, Catherine
    Berthod, Gregoire
    CASE REPORTS IN ONCOLOGY, 2024, 17 (01): : 191 - 201
  • [37] Phase II Study of the MEK1/MEK2 Inhibitor Trametinib in Patients With Metastatic BRAF-Mutant Cutaneous Melanoma Previously Treated With or Without a BRAF Inhibitor
    Kim, Kevin B.
    Kefford, Richard
    Pavlick, Anna C.
    Infante, Jeffrey R.
    Ribas, Antoni
    Sosman, Jeffrey A.
    Fecher, Leslie A.
    Millward, Michael
    McArthur, Grant A.
    Hwu, Patrick
    Gonzalez, Rene
    Ott, Patrick A.
    Long, Georgina V.
    Gardner, Olivia S.
    Ouellet, Daniele
    Xu, Yanmei
    DeMarini, Douglas J.
    Le, Ngocdiep T.
    Patel, Kiran
    Lewis, Karl D.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04) : 482 - 489
  • [38] High BRAF V600 Mutation Level Associated with Worse Outcome in Metastatic Melanoma Patients Receiving BRAF and MEK Inhibitors
    Fizazi, Ariane
    Serrand, Chris
    Evrard, Alexandre
    Bergeret, Blanche
    Stoebner, Pierre-Emmanuel
    Marque, Myriam
    ACTA DERMATO-VENEREOLOGICA, 2024, 104
  • [39] Preexisting MEK1P124 Mutations Diminish Response to BRAF Inhibitors in Metastatic Melanoma Patients
    Carlino, Matteo S.
    Fung, Carina
    Shahheydari, Hamideh
    Todd, Jason R.
    Boyd, Suzanah C.
    Irvine, Mal
    Nagrial, Adnan M.
    Scolyer, Richard A.
    Kefford, Richard F.
    Long, Georgina V.
    Rizos, Helen
    CLINICAL CANCER RESEARCH, 2015, 21 (01) : 98 - 105
  • [40] Left ventricular ejection fraction decrease related to BRAF and/or MEK inhibitors in metastatic melanoma patients: A retrospective analysis
    Berger, Mathilde
    Amini-Adle, Mona
    Maucort-Boulch, Delphine
    Robinson, Philip
    Thomas, Luc
    Dalle, Stephane
    Courand, Pierre-Yves
    CANCER MEDICINE, 2020, 9 (08): : 2611 - 2620
12345